1. Home
  2. SCYX vs MIND Comparison

SCYX vs MIND Comparison

Compare SCYX & MIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCYNEXIS Inc.

SCYX

SCYNEXIS Inc.

N/A

Current Price

$4.44

Market Cap

51.4M

Sector

Health Care

ML Signal

N/A

Logo MIND Technology Inc. (DE)

MIND

MIND Technology Inc. (DE)

HOLD

Current Price

$4.06

Market Cap

43.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCYX
MIND
Founded
1999
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
51.4M
43.0M
IPO Year
2014
1997

Fundamental Metrics

Financial Performance
Metric
SCYX
MIND
Price
$4.44
$4.06
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
64.8K
105.7K
Earning Date
05-06-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
61.36
29.77
EPS
N/A
N/A
Revenue
$257,000.00
$42,675,000.00
Revenue This Year
N/A
$23.31
Revenue Next Year
$608.78
$1.01
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$3.63
52 Week High
$6.09
$14.50

Technical Indicators

Market Signals
Indicator
SCYX
MIND
Relative Strength Index (RSI) 38.72 41.35
Support Level $0.67 N/A
Resistance Level $5.56 $5.46
Average True Range (ATR) 0.34 0.23
MACD -0.12 -0.01
Stochastic Oscillator 0.63 51.40

Price Performance

Historical Comparison
SCYX
MIND

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in single segment namely, Seamap which provides services and products, including engineering, repairs and software licensing, utilized in marine exploration, marine survey and maritime security for marine survey companies, seismic survey contractors, research institutes, non-military government organizations and operators of port facilities and other offshore installations. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.

Share on Social Networks: